YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.46 CNY | -3.24% |
|
-2.68% | -26.57% |
| 07/05 | US FDA Grants Clinical Trial Approval for Dongcheng Biochemicals' Injection | MT |
| 29/04 | Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug | MT |
Evolution of the average Target Price on Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
Price target over the last 5 years
History of analyst recommendation changes
441645c6289492a6f6089.lE7pQr9hJWDDVgt3nra8jqx7BmoNfo7ri0lEQZetZFw.0TidA_BUaCm5H1g0ytPO5uQIRQ5MSueq4X4FdPHgLh_VN4gIjhtjOvIfQg~87468cea97a0c4d251023d78778aa9cb
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
13.46
CNY
Average target price
19.9
CNY
Spread / Average Target
+47.85%
High Price Target
22
CNY
Spread / Highest target
+63.45%
Low Price Target
17.8
CNY
Spread / Lowest Target
+32.24%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002675 Stock
- Consensus Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
